


HY000270 by Applied Biological Materials (ABM) is a mouse monoclonal antibody (clone IHC132, IgG1) that specifically targets the IDH1 R132H point mutation in human tissue. Validated for IHC at 1:50–1:200 and ELISA, it is used in neuropathology workflows for glioma classification where IDH mutational status is required. MBP is a registered vendor for Howard Hughes Medical Institute, Vanderbilt University, and MD Anderson Cancer Center.